Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

CANCER

Prostate cancer hijacks the microenvironment

Nature Cell Biology volume 23, pages 3–5 (2021)Cite this article

Subjects

Prostate cancer is difficult to treat because of molecular, cellular and clinical heterogeneity. Using single-cell RNA sequencing, a recent study reveals unexpected transcriptomic reprograming in immune cells and non-immune components of the tumour microenvironment, which may lead to viable therapeutic approaches against prostate cancer.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Prostate cancer enables the establishment of a metastatic TME niche.

References

  1. Siegel, R. L., Miller, K. D. & Jemal, A. CA Cancer J. Clin. 70, 7–30 (2020).

    Article  Google Scholar 

  2. Metzger, A. L. et al. Prostate 79, 1452–1456 (2019).

    Article  Google Scholar 

  3. Chen, S. et al. Nat. Cell Biol. https://doi.org/10.1038/s41556-020-00613-6 (2021).

  4. Wojno, K. J. & Epstein, J. I. Am. J. Surg. Pathol. 19, 251–260 (1995).

    Article  CAS  Google Scholar 

  5. Cuzick, J. et al. Lancet Oncol. 12, 245–255 (2011).

    Article  CAS  Google Scholar 

  6. Logothetis, C. J. & Lin, S.-H. Nat. Rev. Cancer 5, 21–28 (2005).

    Article  CAS  Google Scholar 

  7. Sica, A. et al. Semin. Cancer Biol. 18, 349–355 (2008).

    Article  CAS  Google Scholar 

  8. Heck, M. M. et al. Eur. Urol. 66, 222–229 (2014).

    Article  Google Scholar 

  9. Lunger, L. et al. Prostate Cancer Prostatic Dis. https://doi.org/10.1038/s41391-020-00283-3 (2020).

  10. Nguyen, M. et al. Cell Rep. 25, 3884–3893.e3 (2018).

    Article  CAS  Google Scholar 

  11. Becker, L. M. et al. Cell Rep. 31, 107701 (2020).

    Article  CAS  Google Scholar 

  12. Vickman, R. E. et al. Prostate 80, 173–185 (2020).

    Article  CAS  Google Scholar 

  13. Ayala, G. et al. Clin. Cancer Res. 9, 4792–4801 (2003).

    CAS  PubMed  Google Scholar 

  14. Schaaf, M. B., Garg, A. D. & Agostinis, P. Cell Death Dis. 9, 115 (2018).

    Article  Google Scholar 

  15. Queisser, A. et al. Mod. Pathol. 28, 138–145 (2015).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department for BioMedical Research, University of Bern, Bern, Switzerland

    Phillip Thienger & Mark A. Rubin

  2. Bern Center for Precision Medicine, University of Bern and Inselspital, Bern, Switzerland

    Mark A. Rubin

Authors
  1. Phillip Thienger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mark A. Rubin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mark A. Rubin.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Thienger, P., Rubin, M.A. Prostate cancer hijacks the microenvironment. Nat Cell Biol 23, 3–5 (2021). https://doi.org/10.1038/s41556-020-00616-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41556-020-00616-3

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer